In contrast, the benefit in pancreatic cancer was more modest and did not reach statistical significance (OR = 1.59, 95% CI: 0.74–3.43), suggesting that pancreatic tumors may be more resistant to this combinatorial strategy.
← all excerpts
Effectiveness, safety, and the abscopal effect of stereotactic body radiation therapy combined with immune checkpoint inhibitors in advanced gastrointestinal cancers: a systematic review and meta-analysis.
1
—
—